QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis CaseStudy_CD155 Expression in Metastatic Melanoma and Anti-PD1 resistance
922 views
In this video, Eric Seiser, Ph.D, Sr. Field Application Scientist will be demonstrating a use case of QIAGEN Ingenuity Pathway Analysis for interpreting the biology of gene expression based omics dataset. The focus will be on a recent study on a potential therapeutic target CD155 for Metastatic Melanoma patients that demonstrate resistance to Anti-PD1 based therapies
Related videos
QIAGEN IPA
Exploring COVID-19 implicated genes in QIAGEN IPA and OmicSoft Land Explorer
Interested in learning more? Click here
QIAGEN IPA
Analyze, compare and contextualize your biological data with QIAGEN IPA
Discover why QIAGEN Ingenuity Pathway Analysis (IPA) is more than just...
QIAGEN IPA
IPA Webinar: Part 1: Introduction to Ingenuity Pathway Analysis
Learn how to quickly and easily identify significant pathways, discover...
QIAGEN IPA
IPA Webinar: Part 2: Formatting and Uploading Your Dataset into IPA
IPA has broadly been adopted by the life science research community and is...